Entity Name: | MEDEXUS PHARMA, INC. |
Jurisdiction: | FLORIDA |
Filing Type: | Foreign Profit |
Status: |
Active
The business entity is active. This status indicates that the business is currently operating and compliant with state regulations, suggesting a lower risk profile for lenders and potentially better creditworthiness. |
Date Filed: | 28 May 2014 (11 years ago) |
Last Event: | NAME CHANGE AMENDMENT |
Event Date Filed: | 12 Mar 2019 (6 years ago) |
Document Number: | F14000002378 |
FEI/EIN Number |
455634664
Federal Employer Identification (FEI) Number assigned by the IRS. |
Address: | 29 N. WACKER DR., SUITE 704, CHICAGO, IL, 60606 |
Mail Address: | 29 N. WACKER DR., SUITE 704, CHICAGO, IL, 60606 |
Place of Formation: | DELAWARE |
Name | Role | Address |
---|---|---|
d'Entremont Ken | Director | 29 N. WACKER DR., SUITE 704, CHICAGO, IL, 60606 |
Buschman Brendon | Director | 29 N. WACKER DR., SUITE 704, CHICAGO, IL, 60606 |
Adelman Michael | Director | 29 N. WACKER DR., SUITE 704, CHICAGO, IL, 60606 |
Poncy William | Secretary | 29 N. WACKER DR., SUITE 704, CHICAGO, IL, 60606 |
Brown Ian W | Asst | 29 N. WACKER DR., SUITE 704, CHICAGO, IL, 60606 |
CORPORATION SERVICE COMPANY | Agent | - |
Event Type | Filed Date | Value | Description |
---|---|---|---|
NAME CHANGE AMENDMENT | 2019-03-12 | MEDEXUS PHARMA, INC. | - |
AMENDMENT | 2014-11-18 | - | - |
Name | Date |
---|---|
ANNUAL REPORT | 2025-01-10 |
ANNUAL REPORT | 2024-03-08 |
ANNUAL REPORT | 2023-03-30 |
ANNUAL REPORT | 2022-04-21 |
ANNUAL REPORT | 2021-04-23 |
ANNUAL REPORT | 2020-03-10 |
Name Change | 2019-03-12 |
ANNUAL REPORT | 2019-01-22 |
ANNUAL REPORT | 2018-01-09 |
AMENDED ANNUAL REPORT | 2017-04-25 |
Date of last update: 03 Mar 2025
Sources: Florida Department of State